Showing results (1-10 of 305) with videos related to
Sort By:
Pageof 31
Journal of Basic and Clinical Physiology and Pharmacology|April 10, 2024
Pozelimab, a human monoclonal immunoglobulin for the treatment of CHAPLE diseaseManmeet Kaur, Saurav MisraJournal of Basic and Clinical Physiology and Pharmacology|July 8, 2024
Deucravacitinib: moderate-to-severe plaque psoriasis preventable?Manmeet Kaur, Saurav MisraEuropean Journal of Clinical Pharmacology|February 17, 2024
A review of an investigational drug retatrutide, a novel triple agonist agent for the treatment of obesityManmeet Kaur, Saurav MisraJournal of Basic and Clinical Physiology and Pharmacology|October 10, 2024
Bimagrumab: an investigational human monoclonal antibody against activin type II receptors for treating obesityManmeet Kaur, Saurav MisraJournal of Basic and Clinical Physiology and Pharmacology|July 16, 2025
A critical comparison of pharmacovigilance reporting forms in six countries with the WHO-UMC recommendations (form of the form)Saurav Misra, Manmeet Kaur, Jayant Kumar KairiJournal of Basic and Clinical Physiology and Pharmacology|November 26, 2025
Interleukin-23 (IL-23) inhibitor, mirikizumab in the treatment of ulcerative colitis (UC): a promising therapy?Saurav Misra, Manmeet Kaur, Ashish Kumar SaranjhnaJournal of Basic and Clinical Physiology and Pharmacology|July 29, 2025
Efficacy and safety of retatrutide for the treatment of obesity: a systematic review of clinical trialsSaurav Misra, Ravi Kant Narayan, Manmeet KaurJournal of Basic and Clinical Physiology and Pharmacology|December 9, 2025
An overview and comparison of haemovigilance reporting forms across six countries relative to the WHO templateManmeet Kaur, Saurav Misra, Jayant Kumar KairiJournal of Family Medicine and Primary Care|November 24, 2025
Causality, severity, seriousness, and preventability of adverse drug reactions: A retrospective analysisSaurav Misra, Tirthankar Deb, Manmeet Kaur, et al.Journal of Family Medicine and Primary Care|May 13, 2024
Adverse events following Covaxin administration among adolescents (15-18 years) - A pharmacovigilance study in a district in Northern IndiaTirthankar Deb, Manmeet Kaur, Saurav Misra, et al.Pageof 31